Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 10201 - 10225 of 10874 in total
Prulifloxacin has been investigated for the treatment of Urinary Tract Infection.
Investigational
Matched Iupac: … 6-fluoro-1-methyl-7-{4-[(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl]piperazin-1-yl}-4-oxo-1H,4H-[1,3]thiazeto …
Matched Description: … Prulifloxacin has been investigated for the treatment of Urinary Tract Infection. …
PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
Investigational
Matched Description: … PF-04447943 has been investigated for the treatment of Alzheimer's Disease. …
Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic.
Investigational
Matched Iupac: … (1R,2R)-1-[(2S,4R)-4-({8-chloro-7-[2-(morpholin-4-yl)ethoxy]-2-{2-[(propan-2-yl)amino]-1,3-thiazol-4- …
Matched Description: … Vedroprevir has been investigated for the treatment of Hepatitis C, Chronic. …
Sovaprevir has been investigated for the treatment of Hepatitis C, Chronic.
Investigational
Matched Iupac: … -(piperidin-1-yl)butanoyl]-N-[(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl]-4-[(7- …
Matched Description: … Sovaprevir has been investigated for the treatment of Hepatitis C, Chronic. …
MDT-637 has been investigated for the treatment of Drug Safety.
Investigational
Matched Description: … MDT-637 has been investigated for the treatment of Drug Safety. …
Tozadenant has been investigated for the basic science of Cocaine Dependence.
Investigational
Matched Iupac: … 4-hydroxy-N-[4-methoxy-7-(morpholin-4-yl)-1,3-benzothiazol-2-yl]-4-methylpiperidine-1-carboxamide …
Matched Description: … Tozadenant has been investigated for the basic science of Cocaine Dependence. …
BIIB021 has been investigated for the treatment of Tumors and Lymphoma.
Investigational
Matched Description: … BIIB021 has been investigated for the treatment of Tumors and Lymphoma. …
Nissel has been investigated for the treatment of Chronic Liver Disease.
Investigational
Matched Description: … Nissel has been investigated for the treatment of Chronic Liver Disease. …
Forigerimod is under investigation for the treatment of Lupus Erythematosus, Systemic.
Investigational
Matched Description: … Forigerimod is under investigation for the treatment of Lupus Erythematosus, Systemic. …
Setipiprant has been investigated for the treatment of Seasonal Allergic Rhinitis.
Investigational
Matched Description: … Setipiprant has been investigated for the treatment of Seasonal Allergic Rhinitis. …
Fosbretabulin has been investigated for the treatment of Anaplastic Thyroid Cancer.
Investigational
Matched Description: … Fosbretabulin has been investigated for the treatment of Anaplastic Thyroid Cancer. …
Combretastatin has been investigated for the treatment of Anaplastic Thyroid Cancer.
Investigational
Matched Description: … Combretastatin has been investigated for the treatment of Anaplastic Thyroid Cancer. …
Spiradoline has been investigated for the basic science of Bipolar Depression.
Investigational
Matched Iupac: … 2-(3,4-dichlorophenyl)-N-methyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide …
Matched Description: … Spiradoline has been investigated for the basic science of Bipolar Depression. …
Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia.
Investigational
Matched Description: … Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia. …
From Centella asiatica and other plants; shows a variety of bioactivities.
Experimental
Matched Description: … From Centella asiatica and other plants; shows a variety of bioactivities. …
CA-170 is a selective, small molecule inhibitor of PD-L1.
Investigational
Matched Description: … CA-170 is a selective, small molecule inhibitor of PD-L1. …
OSSM-007 consists of interferon-gamma primed allogeneic mesenchymal stem cells.
Investigational
Matched Description: … OSSM-007 consists of interferon-gamma primed allogeneic mesenchymal stem cells. …
APL-030 is a orally-active small molecule inhibitor of GCN2.
Investigational
Matched Description: … APL-030 is a orally-active small molecule inhibitor of GCN2. …
Entinostat is under investigation for the treatment and other of Volunteers, Breast Cancer, Human Volunteers, and Normal Volunteers. Entinostat has been investigated for the treatment of Non-Small Lung Cancer, Epigenetic Therapy.
Investigational
Matched Description: … Entinostat has been investigated for the treatment of Non-Small Lung Cancer, Epigenetic Therapy. ... Entinostat is under investigation for the treatment and other of Volunteers, Breast Cancer, Human Volunteers …
Olaptesed Pegol has been investigated for the treatment of Hematopoietic Stem Cell Transplantation.
Investigational
Matched Description: … Olaptesed Pegol has been investigated for the treatment of Hematopoietic Stem Cell Transplantation. …
Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain.
Investigational
Matched Description: … Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain. …
Apaziquone has been investigated for the treatment of Bladder Cancer and Bladder Neoplasms.
Investigational
Matched Description: … Apaziquone has been investigated for the treatment of Bladder Cancer and Bladder Neoplasms. …
Pancreatic Polypeptide has been investigated for the treatment of Diabetes Mellitus, Type 1.
Investigational
Matched Description: … Pancreatic Polypeptide has been investigated for the treatment of Diabetes Mellitus, Type 1. …
Iowh032 has been investigated for the treatment of Cholera, Diarrhea, and Secretory Diarrhea.
Investigational
Matched Description: … Iowh032 has been investigated for the treatment of Cholera, Diarrhea, and Secretory Diarrhea. …
S65487 a potent and selective BCL-2 inhibitor, and a prodrug of S55746.
Investigational
Matched Description: … S65487 a potent and selective BCL-2 inhibitor, and a prodrug of S55746. …
Displaying drugs 10201 - 10225 of 10874 in total